Extrarenal complications of the nephrotic syndrome (Q40738053)

23 September 2017

1 reference

title

Extrarenal complications of the nephrotic syndrome (English)

1 reference

23 September 2017

Harris RC

1

1 reference

PubMed ID

8154483

23 September 2017

Ismail N

series ordinal

2

1 reference

PubMed ID

8154483

23 September 2017

language of work or name

1 reference

1 April 1994

1 reference

American Journal of Kidney Diseases

23 September 2017

1 reference

23 September 2017

23

1 reference

23 September 2017

4

1 reference

23 September 2017

477-497

1 reference

Hepatic Secretion of Lipoproteins in the Rat and the Effect of Experimental Nephrosis

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

A low-protein diet restricts albumin synthesis in nephrotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Metabolism of albumin and immunoglobulins in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effect of dietary protein intake on albumin homeostasis in nephrotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effect of albumin concentration and colloid osmotic pressure on albumin synthesis in the perfused rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Lipid abnormalities in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis. I: Studies in rat in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Increased hepatitic cholesterol production due to liver hypertrophy in rat experimental nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Serum lipid and lipoprotein alterations in nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effects of dextran, polyvinylpyrrolidone and gamma globulin on the hyperlipidemia of experimental nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Regulation of apolipoprotein gene expression and plasma high-density lipoprotein composition in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Pathogenesis of hyperlipidemia in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Catabolism of very low density lipoproteins in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

In vivo studies of the role of albumin in endogenous and heparin-activated lipemia-clearing in nephrotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Lipoprotein distribution and composition in the human nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Impaired renal mevalonate metabolism in nephrotic syndrome: a stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Chylous ascites and the nephrotic syndrome. Report of a case, associated with renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Chylothorax: a complication of the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Lipid changes in the nephrotic syndrome: New insights into pathomechanisms and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Sodium Retention in Nephrotic Syndrome Is Due to an Intrarenal Defect: Evidence from Steroid-Induced Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Renal function during recovery from minimal lesions nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Clinical course and renal function in minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Functional relationships in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Role of glomerular filtration rate in the impaired sodium and water excretion of patients with the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Blood Volume in Persons with the Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Plasma and blood volumes in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Nephrotic Syndrome: Vasoconstriction and Hypervolemic Types Indicated by Renin-Sodium Profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effect of changes in posture on circulatory homeostasis in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

A study on oedema mechanism in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effect of hypoproteinemia on blood volume recovery after moderate hemorrhage in conscious splenectomized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Restitution of blood volume after hemorrhage: mathematical description

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Transcapillary refilling after hemorrhage in the splenectomized dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Diuretic and hormonal responses to head-out water immersion in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effects of water immersion on renal function in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Preservation of blood volume during edema removal in nephrotic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Disposition and diuretic effect of furosemide in the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Furosemide binding to human albumin and plasma of nephrotic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

1 reference

7 January 2021

Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Treatment of nephrosis with concentrated human serum albumin. II. Effects on renal function and on excretion of water and some electrolytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Salt-poor Human Albumin in Management of Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Blood pressure in minimal change and other types of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Lipoid nephrosis appearing as acute oliguric renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Reversible renal failure in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Adult minimal change glomerulopathy with acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Hypercoagulability in the Nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

The clinical spectrum of renal vein thrombosis: acute and chronic

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Chronic renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Peripheral arterial thrombosis due to the nephrotic syndrome: the clinical spectrum.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Clinical correlation between hypercoagulability and thrombo-embolic phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Urokinase Concentration in the Renal Artery and Vein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Streptokinase salvage of renal function after renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Fibrinolytic therapy for bilateral renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Successful thrombolytic therapy in two patients with renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Renal vein thrombosis and nephrotic syndrome. A prospective study of 36 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Renal vein thrombosis in membranous glomerulonephropathy: incidence and association

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Calcium and Vitamin D Homeostasis in the Nephrotic Syndrome: Current Status

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Vitamin-D metabolism in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Calcium and vitamin D metabolism in children with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Osteomalacia and Hyperparathyroid Bone Disease in Patients with Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Absence of Metabolic Bone Disease in Adult Patients with the Nephrotic Syndrome and Normal Renal Function*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Intestinal calcium absorption in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Vitamin D absorption, plasma concentration and urinary excretion of 25-hydroxyvitamin D in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Vitamin D Metabolism in Nephrotic Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Can urinary thyroid hormone loss cause hypothyroidism?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Transferrin Loss into the Urine with Hypochromic, Microcytic Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Studies on copper metabolism. XI. Copper and iron metabolism in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Impaired zinc metabolic status in children affected by idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Decline of vaccine-induced antipneumococcal antibody in children with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Hepatitis B surface antigenaemia and glomerulopathies in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Protein S deficiency occurs in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Molecular markers of hemostasis activation in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

Platelet hyperaggregability and the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980369-6

7 January 2021

10.1016/S0272-6386(12)80369-6

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8154483